Yoshiyuki Yamada Selected Research

Hypereosinophilic Syndrome (Loeffler Endocarditis)

9/2008	FIP1L1/PDGFRalpha synergizes with SCF to induce systemic mastocytosis in a murine model of chronic eosinophilic leukemia/hypereosinophilic syndrome.
5/2006	The FIP1L1-PDGFRA fusion gene cooperates with IL-5 to induce murine hypereosinophilic syndrome (HES)/chronic eosinophilic leukemia (CEL)-like disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshiyuki Yamada Research Topics

Disease

15	Asthma (Bronchial Asthma) 01/2022 - 09/2002
8	Food Hypersensitivity (Food Allergy) 10/2023 - 01/2019
7	Neoplasms (Cancer) 07/2023 - 06/2006
7	Inflammation (Inflammations) 01/2022 - 04/2003
6	Eosinophilia 09/2015 - 05/2006
4	Enterocolitis 10/2023 - 01/2020
4	Infections 02/2013 - 01/2012
3	Proctocolitis (Hemorrhagic Proctocolitis) 10/2023 - 01/2020
3	Respiratory Sounds (Crackle) 01/2022 - 02/2011
3	Bacterial Infections (Bacterial Infection) 01/2022 - 01/2020
3	Systemic Mastocytosis 01/2014 - 09/2008
2	Hypersensitivity (Allergy) 06/2023 - 04/2019
2	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2023 - 01/2019
2	Eosinophilic Esophagitis 01/2023 - 01/2022
2	Fever (Fevers) 01/2020 - 04/2019
2	Tuberculosis (Tuberculoses) 01/2019 - 03/2017
2	Virus Diseases (Viral Diseases) 12/2016 - 01/2008
2	Human Influenza (Influenza) 02/2013 - 01/2012
2	Hypereosinophilic Syndrome (Loeffler Endocarditis) 09/2008 - 05/2006
2	Pdgfra-Associated Chronic Eosinophilic Leukemia 09/2008 - 05/2006
2	Stomach Neoplasms (Stomach Cancer) 10/2007 - 09/2007
2	Pancreatic Neoplasms (Pancreatic Cancer) 07/2007 - 06/2006
1	Transient Myeloproliferative Syndrome 05/2024
1	Suppurative Otitis Media 07/2023
1	Neurologic Manifestations (Neurological Manifestations) 07/2023
1	Burkitt Lymphoma (Burkitt's Lymphoma) 07/2023
1	Iron Deficiencies 12/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2022
1	Milk Hypersensitivity (Milk Allergy) 04/2022
1	Egg Hypersensitivity (Egg Allergy) 04/2022
1	Rhinitis 01/2022
1	Atopic Dermatitis (Atopic Eczema) 01/2022
1	Sinusitis 01/2022
1	Churg-Strauss Syndrome (Allergic Angiitis) 01/2022
1	Hemorrhage 10/2021
1	Capillary Leak Syndrome 01/2020
1	Vomiting 01/2020
1	Sepsis (Septicemia) 01/2020
1	Edema (Dropsy) 04/2019
1	Weight Gain 04/2019
1	Shock 04/2019
1	Extensively Drug-Resistant Tuberculosis 01/2018
1	Autism Spectrum Disorder 05/2017
1	Eosinophilic enteropathy 09/2015
1	Drug Resistant Epilepsy 05/2015
1	Hypoproteinemia 05/2015
1	Protein-Losing Enteropathies (Protein-Losing Enteropathy) 05/2015
1	Lung Injury 02/2013
1	Body Weight (Weight, Body) 01/2013

Drug/Important Bio-Agent (IBA)

14	Immunoglobulin E (IgE)IBA 10/2023 - 01/2011
13	CytokinesIBA 05/2024 - 01/2008
10	Proteins (Proteins, Gene)FDA Link 10/2023 - 01/2008
10	ChemokinesIBA 01/2022 - 09/2002
8	Interleukin-5 (Interleukin 5)IBA 04/2020 - 05/2006
6	Eosinophil Cationic ProteinIBA 01/2022 - 01/2010
5	AllergensIBA 06/2023 - 01/2011
4	C-Reactive ProteinIBA 01/2022 - 04/2019
4	Fluorouracil (Carac)FDA LinkGeneric 09/2007 - 07/2005
4	Paclitaxel (Taxol)FDA LinkGeneric 09/2007 - 06/2006
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2008
3	AntibodiesIBA 01/2020 - 01/2011
3	AntigensIBA 09/2015 - 02/2011
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2014 - 05/2006
3	Interleukin-6 (Interleukin 6)IBA 02/2011 - 01/2008
2	CatalaseIBA 12/2022 - 01/2012
2	Interleukin-8 (Interleukin 8)IBA 04/2020 - 01/2008
2	EnzymesIBA 01/2019 - 01/2012
2	DNA (Deoxyribonucleic Acid)IBA 09/2015 - 02/2011
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2011 - 01/2010
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2011 - 01/2010
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2011 - 01/2010
2	Platelet-Derived Growth Factor alpha ReceptorIBA 01/2009 - 09/2008
1	dupilumabIBA 01/2023
1	Chelating AgentsIBA 12/2022
1	IronIBA 12/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Penicillins (Penicillin)FDA Link 01/2022
1	MacrolidesIBA 01/2022
1	Cephalosporins (Cephalosporin Antibiotics)IBA 01/2022
1	Galectins (Galectin)IBA 01/2022
1	Leucine (L-Leucine)FDA Link 12/2020
1	Interleukin-12 (IL 12)IBA 04/2020
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 04/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2019
1	Prednisolone (Predate)FDA LinkGeneric 09/2019
1	ipomeamaroneIBA 04/2019
1	AlbuminsIBA 04/2019
1	Anthranilate SynthaseIBA 01/2019
1	Peptide Hydrolases (Proteases)FDA Link 03/2017
1	Proton Pump InhibitorsIBA 09/2015
1	Peptides (Polypeptides)IBA 02/2013
1	pHLIP proteinIBA 02/2013
1	Interleukin-17 (Interleukin 17)IBA 01/2013

Therapy/Procedure

8	Therapeutics 07/2023 - 10/2007
5	Drug Therapy (Chemotherapy) 10/2007 - 06/2006
1	Middle Ear Ventilation (Tympanostomy) 07/2023
1	Laminectomy 07/2023
1	Conservative Treatment 10/2021
1	Plasma Exchange 09/2019
1	Ketogenic Diet 05/2015